Claim your 20% discount on Global Market Reports with code ONLINE20. Limited time only.

What CAGR And Valuation Are Anticipated For The Convalescent Plasma Therapy Market?

The market size for convalescent plasma therapy has seen a significant expansion in the recent past. Predictions indicate that it is set to enlarge from $0.05 billion in 2024 to approximately $0.06 billion in 2025, with a Compound Annual Growth Rate (CAGR) of 11.1%. The growth experienced during the historic period is due to factors such as occurrences of pandemics and outbreaks of infectious diseases, research in immunotherapy, the provision of emergency use authorization (eua), patient accessibility, and the awareness of clinicians and the public.

The market size for convalescent plasma therapy is projected to experience remarkable growth in the near future. The market is anticipated to reach $0.09 billion by 2029, with a compound annual growth rate (CAGR) of 13.6%. The anticipated growth throughout the forecast period can be linked to the progression of pathogens, the development of immunotherapies, regulatory structures, global readiness, and initiatives related to public health. Some prominent trends expected to impact the forecast period include standardization of collection and processing, identification of specific plasma components, customized treatment plans, the rise in telemedicine and remote patient monitoring, and investigations into long-term effects.

Get A Free Sample Of The Report:

https://www.thebusinessresearchcompany.com/sample.aspx?id=3233&type=smp

What Core Drivers Are Expected To Influence The Convalescent Plasma Therapy Market?

The growth of the global convalescent plasma therapy market may be propelled during the forecast period by the increased efficacy and safety demonstrated in CPT trials for COVID-19 patients. Historically, convalescent plasma transfusion has been considered for addressing outbreaks of other infectious diseases, including SARS‐1, the Middle East Respiratory Syndrome (MERS), and H1N1 in 2009. A study carried out by Houston Methodist hospital in June 2022, aiming to assess the safety and effectiveness of COVID-19 convalescent plasma therapy, indicated that the therapy is safe with zero reported adverse events and is effective with a recovery rate of 76%. Another study, published in the Journal of Medical Virology in May 2020, suggested that convalescent plasma therapy could lead to a decrease in the mortality rate among critically ill patients, observable improvement in clinical symptoms, and a rise in neutralizing antibody titers along with the disappearance of SARS‐CoV‐2 RNA. The demonstrated safety and efficiency of convalescent plasma therapy for COVID-19 patients are expected to stimulate the growth of the global convalescent plasma therapy market.

What Are The Main Segment Classifications In The Convalescent Plasma Therapy Market?

The convalescent plasma therapymarket covered in this report is segmented –

1) By Antibody type: IgM; IgG; IgA

2) By Application: Prophylaxis; Treatment

3) By End-Users: Hospitals And Clinics; Laboratories And Research institutes

Subsegments:

1) By IgM: Early-Stage Infection Plasma; Acute Phase Plasma; Other IgM-Based Plasma Products

2) By IgG: High Titer IgG Plasma; Standard IgG Plasma; Other IgG-Based Plasma Products

3) By IgA: Plasma Rich In IgA; Specific IgA Antibody Plasma; Other IgA-Based Plasma Products

Which Emerging Trends Are Reshaping The Convalescent Plasma Therapy Market Landscape?

The progression in antibody-related immunotherapy as a possible remedy for COVID-19 presents potential prospects for the convalescent plasma therapy market. This therapy makes use of antibodies developed against coronavirus by the donor to enhance the immunity of the recipient. Firms have begun trials, collaborations, and investments for antibody driven COVID-19 therapy. In August 2023, Regeneron Pharmaceuticals Inc., a biotech firm based in the US, collaborated with the Biomedical Advanced Research and Development Authority (BARDA) to contribute in clinical development, manufacturing, and regulatory licensing of next-gen COVID-19 mono-clonal antibody treatment for averting SARS-CoV-2 contamination. This collaboration is part of Project NextGen, a measure by the U.S Department of Health and Human Services (HHS) to build a modern COVID-19 vaccine and treatment pipeline. In line with the project’s foundations, Regeneron will independently research and propose an antibody option, which BARDA and Regeneron will subsequently evaluate and select for further research, manufacturing, and regulatory endeavors. The emphasis on antibody-driven COVID-19 treatment is anticipated to fuel the growth market of convalescent plasma therapy, considering this therapy employs antibodies.

Which Companies Are Contributing Significantly To The Convalescent Plasma Therapy Market Growth?

Major companies operating in the convalescent plasma therapy market include Bio Farma, Hilton Pharma Ltd., Biotest AG, BPL Ltd., LFB SA, Octapharma AG, CSL Behring LLC, Takeda Pharmaceutical Company Ltd., Orthosera Kft., ADMA Biologics Inc., GC Biopharma Corp, Grifols S.A, Sanquin Plasma Products B.V., America’s Blood Centers, Blood Centers of America Inc., Anthem Inc., Laboratory Corporation of America Holdings, Cerus Corporation, Emergent BioSolutions Inc., Kedrion Biopharma Inc., New York Blood Center, Blood Systems Inc., OneBlood Inc., Gulf Coast Regional Blood Center, Bloodworks Northwest, Blood Assurance Inc., New York Blood Center Inc., Honolulu Blood-Plasma Bank, Community Blood Center, LifeStream Blood Bank

Access The Complete Report Here:

https://www.thebusinessresearchcompany.com/report/convalescent-plasma-therapy-global-market-report

Which Region Holds The Greatest Opportunity For Convalescent Plasma Therapy Market Expansion?

North America was the largest region in the convalescent plasma therapy market in 2024. Western Europe was the second largest region in the convalescent plasma therapy market. The regions covered in the convalescent plasma therapy market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

Customize Your Report Here:

https://www.thebusinessresearchcompany.com/customise?id=3233&type=smp

Browse Through More Reports Similar to the Global Convalescent Plasma Therapy Market 2025, By The Business Research Company

Plasmas Therapy Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/plasmas-therapy-global-market-report

Plasma Fractionation Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/plasma-fractionation-global-market-report

Porcine Plasma Feed Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/porcine-plasma-feed-global-market-report

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Asia +44 7882 955267 & +91 8897263534

Europe +44 7882 955267

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model